Akademik Veri Yönetim Sistemi
4 TH HEALTH SCIENCES AND INNOVATION CONGRESS, Baku, Azerbaycan, 5 - 06 Temmuz 2021, ss.96-102
ABSTRACT
Extra-anatomic bypass (EAB) refer to applications outside the natural anatomical pathway
which are well-recognized method of lower extremity revascularization in patients with
aortoiliac occlusive disease. In this study, we analysed the results of extra-anatomic bypass
procedures over a 22-year period based on 30-day morbidity and mortality and 1 month, 1, 3
and 5 year patient survival, primary patency and limb salvage rates.
A retrospective review and analyse was performed on a single centre database of consecutive
46 patients who underwent femoro-femoral or axillo-femoral grafting procedures during the
period from 1998 to 2020. All patients were followed-up and graft patency determined by
clinical and color dopler ultrasonography (CDUS) assessment. The surviving patients were
Followed-up for 5 years. Five-year survival, graft patency and limb slvage rates were calculated
by the Kaplan–Meier method.
The 46 subjects included 25 (54.3%) femoral and 21 (45.7%) axillary applications. The mean
age was 64.2 ± 12.8 years (28-82) and 36 were male (78.3%). Critical limb ischaemia was the
most accounted indication for EAB surgery (25 /54.4%). The cumulative mortality rate was
34.8% at five year period. The graft patency and limb salvage rates for femoral and axillary
applications were 59.2% vs 57.4% and 86.4% vs 80% at 5 year, respectively.
Femorofemoral and axillofemoral bypasses are suitable for patients with aortoiliac occlusive
disease requiring revascularization for relief of symptoms or for limb salvage, who are not
candidates for endovascular therapy or who are at high risk for direct anatomical
revascularization.
Keywords: Axillofemoral graft; Femorofemoral graft; Long-term graft patency; Long-term
limb salvage; Long-term survival.